Bilsborrow P.E., Evans E.J., Bowman J. et al. (1998) Contamination of edible double-low oilseed rape crops via pollen transfer from high erucic cultivars, J. Sci. Food Agr. 76, 17–22.
Conko G. (2003) Safety, risk and the precautionary principle: Rethinking precautionary approaches to the regulation of transgenic plants, Transgenic Res. 12, 639–647.
Daniell H., Khan M.S., Allison L. (2002) Milestones in chloroplast genetic engineering: An environmentally friendly era in biotechnology, Trends Plant Sci. 7, 84–91.
Editors of Nature Biotechnology (2004) Drugs in crops — the unpalatable truth, Nat. Biotechnol. 22, 133.
Elbehri A. (2005) Biopharming and the food system: Examining the potential benefits and risks, AgBioForum 8, 18–25.
Ellstrand N.C. (2006) When crop transgenes wander in California, should we worry? Calif. Agr. 60, 116–125.
EuropaBio (2006) Understanding coexistence: Science, principles and practical experience, ABE/EuropaBio. www.europa-bio.be/documents/040406/Understanding%20Coexistence%20Fact %20File.pdf.
Federal Register (2003) Field testing of plants engineered to produce pharmaceutical and industrial compounds, Fed. Reg. 68, 11337–11340.
Fischer R., Stoger E., Schillberg S. et al. (2004) Plant-based production of biopharmaceuticals, Curr. Opin. Plant Biol. 7, 152–158.
Giddings G., Allison G., Brooks D. et al. (2000) Transgenic plants as factories for biopharmaceuticals, Nat. Biotechnol. 18, 1151–1155.
Horn M.E., Woodward S.L., Howard J.A. (2004) Plant molecular farming: Systems and products, Plant Cell Rep. 22, 711–720.
Keenan R.J., Stemmer W.P.C. (2002) Nontransgenic crops from transgenic plants, Nat. Biotechnol. 20, 215–216.
Kirk D.D., McIntosh K., Walmsley A.M. et al. (2005) Risk analysis for plant-made vaccines, Transgenic Res. 14, 449–462.
Ma J.K.-C., Drake P.M.W., Christou P. (2003) The production of recombinant pharmaceutical proteins in plants, Nat. Rev. Genet. 4, 794–805.
Ma J.K.-C., Barros E., Bock R. et al. (2005a) Molecular farming for new drugs and vaccines, EMBO Rep. 6, 593–599.
Ma J.K.-C., Chikwamba R., Sparrow P. et al. (2005b) Plant-derived pharmaceuticals — the road forward, Trends Plant Sci. 10, 580–585.
Macilwain C. (2005) US launches probe into sales of unapproved transgenic corn, Nature 434, 423.
Marvier M., Van Acker R. (2005) Can crop transgenes be kept on a leash? Front. Ecol. Environ. 3, 99–106.
Mascia P.N., Flavell R.B. (2004) Safe and acceptable strategies for producing foreign molecules in plants, Curr. Opin. Plant Biol. 7, 189–195.
National Research Council (2004) Biological Confinement of Genetically Engineered Organisms, Naticnal Academy Press Washington, DC, 284 p.
O’Brien M. (2000) Making Better Environmental Decisions: An Alternative to Risk Assessment, MIT Press, Cambridge, MA, 352 p.
Peterson R.K.D., Arntzen C.J. (2004) On risk and plant-based biopharmaceuticals, Trends Biotechnol. 22, 64–66.
Raskin I., Ribnicky D.M., Komarnytsky S. et al. (2002) Plants and human health in the twenty-first century, Trends Biotechnol. 20, 522–531.
Sala F., Rigano M.M., Barbante A. et al. (2003) Vaccine antigen production in transgenic plants: Strategies, gene constructs and perspectives, Vaccine 21, 803–808.
Stewart P.A., Knight A.J. (2005) Trends affecting the next generation of U.S. agricultural biotechnology: Politics, policy, and plant-made Pharmaceuticals, Technol. Forecast Soc. 72, 521–534.
Stewart P.A., McLean W. (2004) Fear and hope over the third generation of agricultural biotechnology: Analysis of public response in the Federal Register, AgBioForum 7, 133–141.
Union of Concerned Scientists (2003) Pharm and Industrial Crops: The Next Wave of Agricultural Biotechnology, Cambridge, MA, www.ucsusa.org/food_and_environment/genetic_engineering/pharm-and-industrial-crops.html.
Union of Concerned Scientists (2007) Pharma Crop Approvals in the United States, Cambridge, MA, http://go.ucsusa.org/food_and_environment/pharm/(accessed Feb.18, 2007).
[USDA] US Department of Agriculture (2005) Audit Report: Animal and Plant Health Inspection Service Controls Over Issuance of Genetically Engineered Organism Release Permits, Office of the Inspector General, Audit #50601-8-Te, December.
[USDA APHIS] Animal and Plant Health Inspection Service (2007) USDA Release Permits for Pharmaceuticals, Industrials, Value Added Proteins for Human Consumption, or for Phytoremediation Granted or Pending by APHIS, www.aphis.usda.gov/brs/ph_permits.html.
Vogel G. (2006) Tracing the transatlantic spread of GM rice, Science 313, 1714.
Walmsley A.M., Arntzen C.J. (2000) Plants for delivery of edible vaccines, Curr. Opin. Biotechnol. 11, 126–129.
Wisner R. (2005) The Economics of Pharmaceutical Crops: Potential Benefits and Risks for Farmers and Rural Communities, Union of Concerned Scientists, Cambridge, MA, www.ucsusa.org/food_and_environment/genetic_engineering/economics-of-pharmaceutical-crops.html.